An in vitro study has shown that the anti-cancer agent osthole induces cell cycle arrest at G2/M phase and blocks proliferation of HNSCC cells via suppressing the PI3K/AKT pathway [41]. The gene discussed is AKT1; the disease is head and neck squamous cell carcinoma.